杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/11/19 | 1,318 | 1,326 | 1,299 | 1,319 | -4 | -0.3% | 253,000 |
| 2010/11/18 | 1,300 | 1,323 | 1,296 | 1,323 | +15 | +1.1% | 323,000 |
| 2010/11/17 | 1,296 | 1,310 | 1,296 | 1,308 | -1 | -0.1% | 100,000 |
| 2010/11/16 | 1,310 | 1,313 | 1,304 | 1,309 | -5 | -0.4% | 104,000 |
| 2010/11/15 | 1,322 | 1,322 | 1,292 | 1,314 | +8 | +0.6% | 186,000 |
| 2010/11/12 | 1,303 | 1,325 | 1,300 | 1,306 | +10 | +0.8% | 314,000 |
| 2010/11/11 | 1,313 | 1,316 | 1,292 | 1,296 | -28 | -2.1% | 485,000 |
| 2010/11/10 | 1,379 | 1,381 | 1,308 | 1,324 | -55 | -4% | 800,000 |
| 2010/11/09 | 1,312 | 1,405 | 1,307 | 1,379 | +65 | +4.9% | 775,000 |
| 2010/11/08 | 1,294 | 1,314 | 1,292 | 1,314 | +5 | +0.4% | 235,000 |
| 2010/11/05 | 1,303 | 1,323 | 1,302 | 1,309 | +3 | +0.2% | 205,000 |
| 2010/11/04 | 1,267 | 1,319 | 1,267 | 1,306 | +45 | +3.6% | 351,000 |
| 2010/11/02 | 1,259 | 1,275 | 1,244 | 1,261 | +10 | +0.8% | 229,000 |
| 2010/11/01 | 1,244 | 1,258 | 1,242 | 1,251 | -5 | -0.4% | 112,000 |
| 2010/10/29 | 1,248 | 1,267 | 1,246 | 1,256 | -4 | -0.3% | 173,000 |
| 2010/10/28 | 1,253 | 1,263 | 1,244 | 1,260 | +7 | +0.6% | 244,000 |
| 2010/10/27 | 1,271 | 1,271 | 1,253 | 1,253 | -13 | -1% | 130,000 |
| 2010/10/26 | 1,280 | 1,280 | 1,264 | 1,266 | -5 | -0.4% | 126,000 |
| 2010/10/25 | 1,294 | 1,297 | 1,259 | 1,271 | -12 | -0.9% | 144,000 |
| 2010/10/22 | 1,279 | 1,284 | 1,268 | 1,283 | +1 | +0.1% | 101,000 |
| 2010/10/21 | 1,286 | 1,288 | 1,273 | 1,282 | -4 | -0.3% | 102,000 |
| 2010/10/20 | 1,304 | 1,304 | 1,266 | 1,286 | -2 | -0.2% | 208,000 |
| 2010/10/19 | 1,279 | 1,290 | 1,274 | 1,288 | +24 | +1.9% | 190,000 |
| 2010/10/18 | 1,259 | 1,272 | 1,255 | 1,264 | -3 | -0.2% | 164,000 |
| 2010/10/15 | 1,285 | 1,285 | 1,263 | 1,267 | -15 | -1.2% | 150,000 |
| 2010/10/14 | 1,285 | 1,289 | 1,272 | 1,282 | +11 | +0.9% | 200,000 |
| 2010/10/13 | 1,265 | 1,280 | 1,258 | 1,271 | +6 | +0.5% | 192,000 |
| 2010/10/12 | 1,307 | 1,307 | 1,261 | 1,265 | -31 | -2.4% | 186,000 |
| 2010/10/08 | 1,312 | 1,313 | 1,294 | 1,296 | -9 | -0.7% | 260,000 |
| 2010/10/07 | 1,301 | 1,315 | 1,298 | 1,305 | ±0 | ±0% | 220,000 |
| 2010/10/06 | 1,317 | 1,320 | 1,302 | 1,305 | -15 | -1.1% | 238,000 |
| 2010/10/05 | 1,304 | 1,323 | 1,300 | 1,320 | +14 | +1.1% | 151,000 |
| 2010/10/04 | 1,348 | 1,348 | 1,296 | 1,306 | -44 | -3.3% | 385,000 |
| 2010/10/01 | 1,310 | 1,360 | 1,308 | 1,350 | +53 | +4.1% | 580,000 |
| 2010/09/30 | 1,299 | 1,306 | 1,295 | 1,297 | -7 | -0.5% | 249,000 |
| 2010/09/29 | 1,295 | 1,306 | 1,294 | 1,304 | -3 | -0.2% | 300,000 |
| 2010/09/28 | 1,295 | 1,312 | 1,289 | 1,307 | -28 | -2.1% | 439,000 |
| 2010/09/27 | 1,348 | 1,353 | 1,310 | 1,335 | -31 | -2.3% | 656,000 |
| 2010/09/24 | 1,330 | 1,368 | 1,327 | 1,366 | +37 | +2.8% | 526,000 |
| 2010/09/22 | 1,310 | 1,333 | 1,295 | 1,329 | -39 | -2.9% | 1,358,000 |
| 2010/09/21 | 1,447 | 1,459 | 1,357 | 1,368 | +161 | +13.3% | 2,148,000 |
| 2010/09/17 | 1,206 | 1,213 | 1,201 | 1,207 | +11 | +0.9% | 175,000 |
| 2010/09/16 | 1,198 | 1,201 | 1,185 | 1,196 | +1 | +0.1% | 131,000 |
| 2010/09/15 | 1,178 | 1,204 | 1,175 | 1,195 | +10 | +0.8% | 141,000 |
| 2010/09/14 | 1,189 | 1,193 | 1,181 | 1,185 | -7 | -0.6% | 102,000 |
| 2010/09/13 | 1,212 | 1,212 | 1,189 | 1,192 | -23 | -1.9% | 123,000 |
| 2010/09/10 | 1,209 | 1,226 | 1,204 | 1,215 | +5 | +0.4% | 159,000 |
| 2010/09/09 | 1,213 | 1,213 | 1,199 | 1,210 | +13 | +1.1% | 200,000 |
| 2010/09/08 | 1,201 | 1,205 | 1,176 | 1,197 | -19 | -1.6% | 245,000 |
| 2010/09/07 | 1,212 | 1,216 | 1,197 | 1,216 | -8 | -0.7% | 200,000 |
3301～
3350
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 171,500円 | +3.2% | +4.5% | 3.03% | 19.70倍 | 0.75倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 持田薬 | 304,500円 | +3.0% | +27.5% | 2.63% | 19.28倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 鳥居薬 | 385,000円 | +7.3% | +16.8% | 3.12% | 23.03倍 | 0.90倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| ゼリア新薬 | 200,100円 | +9.6% | +17.5% | 2.30% | 11.30倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 214,600円 | +7.6% | +57.5% | 2.47% | 16.57倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
